1. Home
  2. QTTB vs AEHR Comparison

QTTB vs AEHR Comparison

Compare QTTB & AEHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QTTB
  • AEHR
  • Stock Information
  • Founded
  • QTTB 2015
  • AEHR 1977
  • Country
  • QTTB United States
  • AEHR United States
  • Employees
  • QTTB N/A
  • AEHR N/A
  • Industry
  • QTTB Biotechnology: Pharmaceutical Preparations
  • AEHR Electrical Products
  • Sector
  • QTTB Health Care
  • AEHR Industrials
  • Exchange
  • QTTB Nasdaq
  • AEHR Nasdaq
  • Market Cap
  • QTTB 434.0M
  • AEHR 451.1M
  • IPO Year
  • QTTB N/A
  • AEHR 1997
  • Fundamental
  • Price
  • QTTB $24.55
  • AEHR $12.16
  • Analyst Decision
  • QTTB Strong Buy
  • AEHR Hold
  • Analyst Count
  • QTTB 6
  • AEHR 2
  • Target Price
  • QTTB $72.33
  • AEHR $12.00
  • AVG Volume (30 Days)
  • QTTB 101.3K
  • AEHR 1.1M
  • Earning Date
  • QTTB 11-07-2024
  • AEHR 01-07-2025
  • Dividend Yield
  • QTTB N/A
  • AEHR N/A
  • EPS Growth
  • QTTB N/A
  • AEHR 53.60
  • EPS
  • QTTB N/A
  • AEHR 0.98
  • Revenue
  • QTTB N/A
  • AEHR $58,713,000.00
  • Revenue This Year
  • QTTB N/A
  • AEHR $9.15
  • Revenue Next Year
  • QTTB N/A
  • AEHR $29.87
  • P/E Ratio
  • QTTB N/A
  • AEHR $12.41
  • Revenue Growth
  • QTTB N/A
  • AEHR N/A
  • 52 Week Low
  • QTTB $9.18
  • AEHR $9.83
  • 52 Week High
  • QTTB $53.79
  • AEHR $30.50
  • Technical
  • Relative Strength Index (RSI)
  • QTTB 16.31
  • AEHR 46.60
  • Support Level
  • QTTB $26.00
  • AEHR $10.97
  • Resistance Level
  • QTTB $51.26
  • AEHR $11.41
  • Average True Range (ATR)
  • QTTB 4.06
  • AEHR 0.67
  • MACD
  • QTTB -2.11
  • AEHR -0.01
  • Stochastic Oscillator
  • QTTB 2.38
  • AEHR 63.07

About QTTB Q32 Bio Inc. Common Stock

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

About AEHR Aehr Test Systems

Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.

Share on Social Networks: